Mitsubishi UFJ Asset Management
ABEO icon

Mitsubishi UFJ Asset Management’s Abeona Therapeutics ABEO Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-781
Closed -$144K – 992
2019
Q1 		$144K Buy
781
+52
+7% +$9.3K ﹤0.01% 837
2018
Q4 		$121K Buy
729
+467
+178% +$102K ﹤0.01% 819
2018
Q3 		$84K Buy
+262
New +$92.9K ﹤0.01% 877

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management's ABEO Position: Q2 2019 in Review

Mitsubishi UFJ Asset Management sold out of Abeona Therapeutics (ABEO) in Q2 2019, closing a stake of 781 shares — an estimated $144K sold.

Mitsubishi UFJ Asset Management first reported a position in ABEO in Q3 2018 and held it in 3 quarters. The position peaked at $144K in Q1 2019. 98 funds tracked by Wall St. Rank hold ABEO as of Q2 2019.

  • Mitsubishi UFJ Asset Management reported no remaining Abeona Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 781 Abeona Therapeutics shares in Q2 2019, an estimated $144K.
  • Mitsubishi UFJ Asset Management first reported a position in Abeona Therapeutics in Q3 2018 and held it in 3 quarters.
  • Mitsubishi UFJ Asset Management's Abeona Therapeutics position peaked at $144K in Q1 2019.
  • 98 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2019.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.